Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Licht

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Biorxiv : the Preprint Server for Biology|November 14, 2023
Recruitment of FBXO22 for Targeted Degradation of NSD2David Y Nie, John R Tabor, Jianping Li, et al.
Nature Chemical Biology|July 4, 2024
Recruitment of FBXO22 for targeted degradation of NSD2David Y Nie, John R Tabor, Jianping Li, et al.
Cell Reports|December 9, 2014
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemiaRaajit Rampal, Altuna Alkalin, Jozef Madzo, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Cell Reports|July 18, 2023
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neckNupur Nigam, Benjamin Bernard, Samantha Sevilla, et al.
Cancer Cell|May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformationWendy Béguelin, Relja Popovic, Matt Teater, et al.
Genome Research|August 22, 2020
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaRaquel Ordoñez, Marta Kulis, Nuria Russiñol, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Blood|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Molecular Cell|May 21, 2021
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J Hogg, Olga Motorna, Leonie A Cluse, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Biorxiv : the Preprint Server for Biology|November 14, 2023
Recruitment of FBXO22 for Targeted Degradation of NSD2David Y Nie, John R Tabor, Jianping Li, et al.
Nature Chemical Biology|July 4, 2024
Recruitment of FBXO22 for targeted degradation of NSD2David Y Nie, John R Tabor, Jianping Li, et al.
Cell Reports|December 9, 2014
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemiaRaajit Rampal, Altuna Alkalin, Jozef Madzo, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Cell Reports|July 18, 2023
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neckNupur Nigam, Benjamin Bernard, Samantha Sevilla, et al.
Cancer Cell|May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformationWendy Béguelin, Relja Popovic, Matt Teater, et al.
Genome Research|August 22, 2020
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaRaquel Ordoñez, Marta Kulis, Nuria Russiñol, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Blood|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Molecular Cell|May 21, 2021
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J Hogg, Olga Motorna, Leonie A Cluse, et al.
Pageof 18